Page last updated: 2024-09-02

5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole and Schizophrenia

5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole has been researched along with Schizophrenia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boulenguez, P; Chauveau, J; Gray, JA; Joseph, MH; Mitchell, SN; Peters, SL1

Other Studies

1 other study(ies) available for 5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole and Schizophrenia

ArticleYear
Dopamine release in the nucleus accumbens and latent inhibition in the rat following microinjections of a 5-HT1B agonist into the dorsal subiculum: implications for schizophrenia.
    Journal of psychopharmacology (Oxford, England), 1998, Volume: 12, Issue:3

    Topics: Animals; Dopamine; Excitatory Amino Acid Antagonists; Glutamic Acid; Hippocampus; Indoles; Male; Microdialysis; Microinjections; Neural Pathways; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Schizophrenia; Serotonin; Serotonin Receptor Agonists

1998